Magnifying Endoscopy With Enhanced Imaging IDs Gastric CA

This article originally appeared here.
Share this content:
Magnifying Endoscopy With Enhanced Imaging IDs Gastric CA
Magnifying Endoscopy With Enhanced Imaging IDs Gastric CA

MONDAY, Sept. 12, 2016 (HealthDay News) -- Magnifying endoscopy with image-enhanced endoscopy (ME-IEE) may provide better diagnostic performance than conventional white light imaging (C-WLI) for early gastric cancer, according to an article published online Aug. 31 in the Journal of Digestive Diseases.

Nei Soma, from Tsinghua University in Beijing, addresses the evaluation of high-risk patients for gastric cancer by endoscopy, focusing on the signs of suspicious lesions by C-WLI or chromoendoscopy (CE). In addition, the author presents endoscopic markers visualized by ME-IEE.

Soma notes that surface and color changes are distinct markers for detecting superficial mucosal neoplasia by C-WLI or CE; other markers include changes in light reflection and spontaneous bleeding. C-WLI endoscopy is the standard imaging modality for diagnosis of gastric mucosal cancers, but diagnosis of minute or superficial flat gastric cancers is difficult using C-WLI or CE; in these cases, advanced imaging is recommended. ME-IEE with narrow-band imaging with a classification system known as the vessel plus surface classification system (VSCS) was effective for identifying early gastric cancer, and may be able to differentiate between low-grade adenoma and early gastric cancer.

"Diagnosis using ME-IEE with VSCS may provide excellent diagnostic performance with high confidence and good reproducibility to the endoscopist if it is performed under consistent conditions, including observation under maximal magnification," Soma writes.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »